Published in

Taylor and Francis Group, Human Vaccines and Immunotherapeutics, 5(15), p. 1126-1132, 2019

DOI: 10.1080/21645515.2019.1571893

Links

Tools

Export citation

Search in Google Scholar

CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO